A China-born scientist was the first of 18 authors on the 2010 paper, which included graphs later shown to have incorrectly labeled healthy human cells as being those from multiple sclerosis\u00a0patients. Liu says he opposes a retraction of the paper. \u00a0\u201cIt was an honest mistake, and it doesn\u2019t affect the findings,\u201d he said, sipping a cappuccino. \u201cI can confidently say that I can recreate the result in any laboratory.\u201d<\/p>\n
The disputed research isn\u2019t part of the investigation of Glaxo China announced in late June by the nation\u2019s Public Security Ministry of alleged economic crimes involving 3 billion yuan \u00a0($489 million) of spurious travel and meeting expenses, and trade in sexual favors. Glaxo\u2019s head of emerging markets of\u00a0Abbas Hussain said on July 22 after meeting with government officials in Beijing that some of its employees may have broken China\u2019s laws. The drugmaker has said it\u2019s cooperating with the government\u2019s investigation.<\/p>\n
Race to Publish Shows Glaxo Zeal to Get Leg Up in China<\/a><\/strong><\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":" A China-born scientist was the first of 18 authors on the 2010 paper, which included graphs later shown to have incorrectly labeled healthy human cells as being those from multiple sclerosis\u00a0patients. Liu says he opposes a retraction of the paper. … Continue reading ![\"Big](\"http:\/\/www.w-t-w.org\/en\/wp-content\/uploads\/2013\/08\/Big-Pharma-300x180.jpg\")
<\/a><\/p>\n